Smoking and prostate cancer

Epidemiologic Reviews

Volumn 23, Issue 1, 2001, Pages 115-125

  Hickey, Kym ^a   Do, Kim Anh ^b   Green, Adele ^c  

^a Repatriation Medical Authority   (Australia)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; SMOKING;

EID: 0034812271     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a000776     Document Type: Review

References (164)

1. Smoking and mortality: A prospective study
2. Epidemiologic characteristics of patients with prostatic neoplasms
3. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the third national cancer survey
4. Cadmium and prostatic carcinoma
5. Incidence of prostatic cancer in Japan and Asia
6. Characterization of prostatic carcinoma among blacks
7. Relative importance of smoking as a risk factor for selected cancers
8. A case-control study of prostate cancer
9. Lifetime occupational physical activity and prostate cancer risk
10. Prostate cancer and work environment
11. Dietary factors and risk of prostate cancer in Poland: Results of case-control study
12. Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders
13. Foods, nutrients and prostate cancer: A case-control study in Uruguay
14. Prostate cancer trends - United States, 1980-1988
15. Prostate cancer: A current perspective
16. Risk factors for prostate cancer
17. Family aggregation of cancer of the prostate in Quebec: The tip of the iceberg
18. Prostate cancer risk in US blacks and whites with a family history of cancer
19. Family history and the risk of prostate cancer
20. Familial patterns of prostate cancer: A case-control analysis
21. Familial prostatic cancer risk and low testosterone
22. Family history and the risk of prostatic carcinoma in a high risk group of urological patients
23. Mendelian inheritance of familial prostate cancer
24. Nutrition and prostate cancer
25. Risk factors for prostate cancer
26. A prospective cohort study of vasectomy and prostate cancer in US men
27. Vasectomy and the risk of prostate cancer in a cohort of multiphasic health-checkup examinees: Second report
28. What causes prostate cancer? A brief summary of the epidemiology
29. A retrospective cohort study of vasectomy and prostate cancer in US men
30. Incidence of disease after vasectomy: A record linkage retrospective cohort study
31. Vasectomy and prostate cancer: Chance, bias, or a causal relationship?
32. Smoking and risk of total and fatal prostate cancer in United States health professionals
33. Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 Norwegian men
34. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States)
35. Cohort study of diet, lifestyle, and prostate cancer in Adventist men
36. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States)
37. Animal fat consumption and prostate cancer: A prospective study in Hawaii
38. Smoking habits and risk of cancers other than lung cancer: 28 Years' follow-up of 26,000 Norwegian men and women
39. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii
40. Physical activity and the risk of prostate and testicular cancer: A cohort study of 53,000 Norwegian men
41. A prospective study of smoking and risk of prostate cancer
42. Various measures of smoking as predictors of cancer of different types in two Finnish cohorts
43. Effects of cigarette smoking on "hormone-related" diseases in a Southern California retirement community
44. Smoking and fatal prostate cancer in a large cohort of adult men
45. Smoking and death rates - Report on forty-four months of follow-up of 187,783 men. II. Death rates by cause
46. Cigarette smoking and cancer mortality risk in Japanese men and women - Results from reanalysis of the six-prefecture cohort study data
47. Tobacco use and prostate cancer: 26-year follow-up of US veterans
48. Mortality in relation to smoking: 40 Years' observations on male British doctors
49. Diet, tobacco use, and fatal prostate cancer: Results from the Lutheran Brotherhood cohort study
50. Mortality in relation to smoking history: 13 Years' follow-up of 68,000 Norwegian men and women 35-49 years
51. Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial
52. Smoking in relation to the death rates of one million men and women
53. Mortality in relation to cigarette and pipe smoking: 16 Years' observation of 25,000 Swedish men
54. Early precursors of urogenital cancers in former college men
55. Heart disease risk factors, diabetes, and prostatic cancer in an adult community
56. Total food consumption and body mass index in relation to prostate cancer risk: A case-control study in Sweden with prospectively collected exposure data
57. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma
58. Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: Seventeen-year follow-up of the prospective Basel study
59. A cohort study of farming and risk of prostate cancer in Iowa
60. Smoking habits and prostate cancer: A case-control study in northern Italy
61. Smoking and drinking habits in relation to prostate cancer
62. Smoking and prostate cancer: An interim analysis of the Australian collaborative case-control study of risk factors for prostate cancer
63. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men
64. Smoking, alcohol, coffee, tea, caffeine, and theobromine: Risk of prostate cancer in Utah (United States)
65. Case-control study of prostate cancer in black patients in Soweto, South Africa
66. Associations between cigarette smoking and each of 21 types of cancer: A multi-site case-control study
67. Cigarette smoking and prostate cancer: No relation with six measures of lifetime smoking habits in a large case-control study among US whites
68. Epidemiology of prostatic cancer: A case-control study
69. More stage A prostatic cancers, less surgery for benign hypertrophy in smokers
70. Case-control studies of cancer in Illinois farmers using data from the Illinois state cancer registry and the US census of agriculture
71. Cigarette smoking and risk of prostate cancer: A population-based case-control study in Ontario and British Columbia, Canada
72. Case-control studies of prostate cancer in blacks and whites in southern California
73. Epidemiological study of prostatic cancer by matched-pair analysis
74. Medical, life-style, and occupational risk factors for prostate cancer
75. Case-control study of prostatic cancer in Kyoto, Japan: Demographic and some lifestyle risk factors
76. Results of a French survey on the role of tobacco, particularly inhalation, in different cancer sites
77. Epidemiologic study of prostatic cancer: Preliminary report
78. Epidemiology of cancer of the prostate
79. Smoking and prostate cancer: A population-based case-control study in Shanghai, China
80. Tobacco use and prostate cancer in blacks and whites in the United States
81. Non-steroidal anti-inflammatory drugs and prostate cancer progression
82. Association between diesel exposure at work and prostate cancer
83. A case-control study of cancer of the prostate in Somerset and East Devon
84. Association between coronary heart disease and cancers of the breast, prostate, and colon
85. Risk factors for prostate cancer: A case-control study in Greece
86. Case-control study of risk factors for prostate cancer
87. A case-control study of diet and prostate cancer
88. Lifestyle factors and prostate cancer risk: A case-control study in Sweden
89. Tobacco, alcohol, diet and risk of prostate cancer
90. Nutritional factors and prostate cancer: A case-control study of French Canadians in Montreal, Canada
91. Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan
92. Identification of occupational cancer risks in British Columbia. Part I: Methodology, descriptive results, and analysis of cancer risks, by cigarette smoking categories of 15,463 incident cancer cases
93. Risk factors for prostate carcinoma in Taiwan
94. Risk factors for prostate cancer: Results from the Canadian national enhanced surveillance system
95. Case-control study of diet and prostate cancer in China
96. Mortality in relation to smoking: 20 Years' observations on male British doctors
97. Sociodemographic and health status characteristics associated with prostate cancer screening in a national cohort of middle-aged male veterans
98. Re: "Tobacco use and prostate cancer: 26-year follow-up of US veterans"
99. Consensus conference: Smoking and prostate cancer
100. Smoking status and dietary fats
101. Dietary differences in smokers and nonsmokers from two southeastern New England communities
102. Interactions between people's diet and their smoking habits: The dietary and nutritional survey of British adults
103. Clustering of dietary variables and other lifestyle factors (Dutch nutritional surveillance system)
104. Mechanisms in multiple risk factor interventions: Smoking, physical activity, and dietary fat intake among manufacturing workers
105. Correlates of high fat/calorie food intake in a worksite population: The Healthy Worker Project
106. Nutritional risk in New England elders
107. Relationship between smoking and diet: The MONICA-France project
108. Relationship between diet and smoking - Is the diet of smokers different?
109. Dietary patterns of women smokers and non-smokers
110. Food and nutrient intake differences between smokers and non-smokers in the US
111. A worse prognosis for smokers with prostate cancer
112. Factors influencing the survival of patients with cancer of the prostate
113. Smoking history and cancer patient survival: A hospital cancer registry study
114. High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean island immigrants
115. Prostatic cancer induced in MRC rats by N-nitrosobis(2-oxopropyl)-amine and N-nitrosobis(2-hydroxypropyl)amine
116. Effects of tobacco smoke on tumor growth and radiation response of Dunning R3327 prostate adenocarcinoma in rats
117. Cadmium and prostate cancer
118. Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: Induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes
119. Modulation of telomerase activity by zinc in human prostatic and renal cancer cells
120. Zinc and cadmium analysis in human prostate neoplasms
121. Occupation, cadmium exposure, and prostate cancer
122. Cancer mortality of cadmium workers
123. Cadmium and prostatic carcinoma
124. Cancer of prostate among nickel-cadmium battery workers
125. Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: A case control study
126. Occupational risk factors for prostate cancer: Results from a case-control study in Montreal, Quebec, Canada
127. Smoking and endogenous sex hormones in men and women
128. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men
129. The role of cigarette smoking in prostatic enlargement
130. Testosterone and cigarette smoking in early adolescence
131. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men: A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants
132. Effects of smoking on testicular function, semen quality and sperm fertilizing capacity
133. Determinants of sex hormone levels in men as useful indices in hormone-related disorders
134. Effects of age, smoking and vitamins on plasma DHEAS levels: A cross-sectional study in men
135. Predictors of sex hormone levels among the elderly: A study in Greece
136. Effect of tobacco consumption on bone mineral density in healthy young males
137. The endocrinology and developmental biology of the prostate
138. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer - A population-based case-control study
139. A prospective, population-based study of androstenedione, estrogens, and prostatic cancer
140. Prediagnostic serum hormones and the risk of prostate cancer
141. Serological precursors of cancer: Serum hormones and risk of subsequent prostate cancer
142. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate
143. Prospective study of sex hormone levels and risk of prostate cancer
144. 5α-reductase activity and prostate cancer: A case-control study using stored sera
145. Serum androgens and prostate cancer
146. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
147. Androgens in serum and the risk of prostate cancer: A nested case-control study from the Janus serum bank in Norway
148. Relationships of serum androgens and estrogens to prostate cancer risk: Results from a prospective study in Finland
149. Endogenous sex hormones and prostate cancer: A quantitative review of prospective studies
150. p53 is mutated in a subset of advanced-stage prostate cancers
151. p53 in prostate cancer: Frequent expressed transition mutations
152. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
153. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma
154. Inactivation of the p53 pathway in prostate cancer: Impact on tumor progression
155. Glutathione S-transferases as risk factors in prostate cancer
156. Glutathione S-transferase-M1 and -T1 genotypes in the etiology of prostate cancer
157. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers
158. Immune function in cigarette smokers who quit smoking for 31 days
159. Longitudinal relation between smoking and white blood cells
160. Smoking and immunity
161. The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate